Literature DB >> 19526285

Metabolic control analysis in a cellular model of elevated MAO-B: relevance to Parkinson's disease.

Jyothi K Mallajosyula1, Shankar J Chinta, Subramanian Rajagopalan, David G Nicholls, Julie K Andersen.   

Abstract

We previously demonstrated that spare respiratory capacity of the TCA cycle enzyme alpha-ketoglutarate dehydrogenase (KGDH) was completely abolished upon increasing levels of MAO-B activity in a dopaminergic cell model system (Kumar et al., J Biol Chem 278:46432-46439, 2003). MAO-B mediated increases in H(2)O(2) also appeared to result in direct oxidative inhibition of both mitochondrial complex I and aconitase. In order to elucidate the contribution that each of these components exerts over metabolic respiratory control as well as the impact of MAO-B elevation on their spare respiratory capacities, we performed metabolic respiratory control analysis. In addition to KGDH, we assessed the activities and substrate-mediated respiration of complex I, pyruvate dehydrogenase (PDH), succinate dehydrogenase (SDH), and mitochondrial aconitase in the absence and presence of complex-specific inhibitors in specific and mixed substrate conditions in mitochondria from our MAO-B elevated cells versus controls. Data from this study indicates that Complex I and KGDH are the most sensitive to inhibition by MAO-B mediated H(2)O(2) generation, and could be instrumental in determining the fate of mitochondrial metabolism in this cellular PD model system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526285      PMCID: PMC2727365          DOI: 10.1007/s12640-009-9032-2

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  33 in total

1.  Mitochondrial complex I deficiency in Parkinson's disease.

Authors:  A H Schapira; J M Cooper; D Dexter; J B Clark; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1990-03       Impact factor: 5.372

2.  Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria.

Authors:  G P Davey; J B Clark
Journal:  J Neurochem       Date:  1996-04       Impact factor: 5.372

3.  Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines.

Authors:  I A Trounce; Y L Kim; A S Jun; D C Wallace
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

4.  Mitochondrial complex I deficiency in Parkinson's disease.

Authors:  A H Schapira; J M Cooper; D Dexter; P Jenner; J B Clark; C D Marsden
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

5.  The sum of flux control coefficients in the electron-transport chain of mitochondria.

Authors:  M D Brand; B P Vallis; A Kesseler
Journal:  Eur J Biochem       Date:  1994-12-15

6.  An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease.

Authors:  Y Mizuno; S Matuda; H Yoshino; H Mori; N Hattori; S Ikebe
Journal:  Ann Neurol       Date:  1994-02       Impact factor: 10.422

7.  Postischemic inhibition of cerebral cortex pyruvate dehydrogenase.

Authors:  Y E Bogaert; R E Rosenthal; G Fiskum
Journal:  Free Radic Biol Med       Date:  1994-06       Impact factor: 7.376

8.  The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach.

Authors:  T Letellier; R Heinrich; M Malgat; J P Mazat
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

9.  Reactive oxygen species-mediated inactivation of pyruvate dehydrogenase.

Authors:  T Tabatabaie; J D Potts; R A Floyd
Journal:  Arch Biochem Biophys       Date:  1996-12-15       Impact factor: 4.013

10.  Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria.

Authors:  A N Murphy; D E Bredesen; G Cortopassi; E Wang; G Fiskum
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  10 in total

Review 1.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

2.  Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study.

Authors:  Sho Moriguchi; Alan A Wilson; Laura Miler; Pablo M Rusjan; Neil Vasdev; Stephen J Kish; Grazyna Rajkowska; Junming Wang; Michael Bagby; Romina Mizrahi; Ben Varughese; Sylvain Houle; Jeffrey H Meyer
Journal:  JAMA Psychiatry       Date:  2019-06-01       Impact factor: 21.596

3.  Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease.

Authors:  Almas Siddiqui; Shankar J Chinta; Jyothi K Mallajosyula; Subramanian Rajagopolan; Ingrid Hanson; Anand Rane; Simon Melov; Julie K Andersen
Journal:  Free Radic Biol Med       Date:  2012-06-15       Impact factor: 7.376

4.  Brain injury and inflammation genes common to a number of neurological diseases and the genes involved in the genesis of GABAnergic neurons are altered in monoamine oxidase B knockout mice.

Authors:  Kevin Chen; Tamara Palagashvili; W Hsu; Yibu Chen; Boris Tabakoff; Frank Hong; Abigail T Shih; Jean C Shih
Journal:  Brain Res       Date:  2021-11-12       Impact factor: 3.252

5.  Assay of MAO Inhibition by Chromatographic Techniques (HPLC/HPLC-MS).

Authors:  Tomás Herraiz
Journal:  Methods Mol Biol       Date:  2023

6.  Antioxidant-Rich Fraction of Urtica dioica Mediated Rescue of Striatal Mito-Oxidative Damage in MPTP-Induced Behavioral, Cellular, and Neurochemical Alterations in Rats.

Authors:  Rohit Bisht; Bhuwan Chandra Joshi; Ajudhiya Nath Kalia; Atish Prakash
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

7.  Rasagiline delays retinal degeneration in a mouse model of retinitis pigmentosa via modulation of Bax/Bcl-2 expression.

Authors:  Ana B Garcia-Delgado; Lourdes Valdés-Sánchez; Sofia M Calado; Francisco J Diaz-Corrales; Shom S Bhattacharya
Journal:  CNS Neurosci Ther       Date:  2018-01-25       Impact factor: 5.243

8.  Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis.

Authors:  Andy Wai Kan Yeung; Maya G Georgieva; Atanas G Atanasov; Nikolay T Tzvetkov
Journal:  Front Mol Neurosci       Date:  2019-05-29       Impact factor: 5.639

9.  Etoposide Induces Mitochondrial Dysfunction and Cellular Senescence in Primary Cultured Rat Astrocytes.

Authors:  Minji Bang; Do Gyeong Kim; Edson Luck Gonzales; Kyoung Ja Kwon; Chan Young Shin
Journal:  Biomol Ther (Seoul)       Date:  2019-11-01       Impact factor: 4.634

10.  Hepatic monoamine oxidase B is involved in endogenous geranylgeranoic acid synthesis in mammalian liver cells.

Authors:  Yuki Tabata; Yoshihiro Shidoji
Journal:  J Lipid Res       Date:  2020-02-24       Impact factor: 5.922

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.